ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 115 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,174,370 | -27.8% | 255,298 | +1.4% | 0.00% | – |
| Q2 2023 | $1,625,814 | -90.1% | 251,674 | -88.4% | 0.00% | -100.0% |
| Q1 2023 | $16,403,631 | +78225.1% | 2,175,548 | +5.2% | 0.00% | -33.3% |
| Q4 2022 | $20,943 | -99.9% | 2,067,513 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $19,633,000 | -4.5% | 1,985,197 | +2.9% | 0.00% | 0.0% |
| Q2 2022 | $20,552,000 | +940.1% | 1,929,798 | +852.0% | 0.00% | – |
| Q1 2022 | $1,976,000 | -31.5% | 202,708 | +0.4% | 0.00% | – |
| Q4 2021 | $2,886,000 | +355.2% | 201,868 | +537.5% | 0.00% | – |
| Q3 2021 | $634,000 | -85.5% | 31,664 | -84.1% | 0.00% | -100.0% |
| Q2 2021 | $4,372,000 | -34.2% | 198,738 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $6,640,000 | -13.2% | 195,537 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $7,649,000 | – | 190,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |